Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology/Infectious Diseases
Clinical Trials: Hepatitis B
A listing of clinical trials currently looking for volunteers to enroll in Hepatitis B studies. Click on the closest city to find more detailed information on a research study in your area.
California
Bakersfield : The Office of Dr. Franco Antonio Felizarta, M.D.
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Garden Grove : Sc Clinical Research, Inc.
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Los Angeles : AIDS Research Alliance
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Los Angeles :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Los Angeles : Asian Pacific Liver Center Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Oakland : Alameda County Medical Center
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Palo Alto : Stanford University
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List
Palo Alto : Stanford University Medical Center,750 Welch Road, Ste. 210 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Sacramento : University of California Davis Research
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Sacramento : University of California
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Sacramento : University Of California Davis Medical Center
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
San Diego : Research and Education Inc Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
San Francisco : University Of California, San Francisco
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
San Francisco : Dr. Philip Rosenthal
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
San Francisco : UCSF - San Fancisco General Hospital
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
San Jose : San Jose Gastroenterology Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Connecticut
Hartford : Connecticut Children'S Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Hartford : Connecticut Children'S Medical Center
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
New Haven : Yale University School Of Medicine
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Florida
Gainesville : University Of Florida
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Gainesville : University Of Florida
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Maitland : Centre for Advanced Gastroenterology Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Miami : Community AIDS Resource Inc dba Care Resource
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Miami : University of Miami / Jackson Memorial Medical Center Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Tampa : University of South Florida Health - HIV Clinical Research Unit
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Wilton Manors : Rowan Tree Medical, P.A.
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Georgia
Atlanta : Romero, Rene
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Atlanta : Atlanta Gastroenterology Associates
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Atlanta :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Illinois
Chicago : University of Chicago Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Indiana
Inidanapolis : Indiana University School Of Medicine / Riley Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Iowa
Iowa City : University of Iowa Hospitals and Clinics
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Kansas
Kansas city : University of Kansas Medical Center,3901 Rainbow Blvd, MS 1023 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Louisiana
New Orleans : LSU Gastroenterology/Center for Digestive Diseases Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Maryland
Baltimore : Johns Hopkins School Of Medicine
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Baltimore : Johns Hopkins School Of Medicine
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Baltimore : Mercy Medical Center
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Baltimore : Digestive Disease Associates Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Colombia : Gastro Center Of Maryland
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Massachusetts
Boston : Shah, Uzma
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Children'S Hospital Boston
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Boston : Children'S Hospital Boston
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Boston : BIDMC
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Boston : Massachusetts General Hospital
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List
Michigan
Detroit : Henry Ford Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Minnesota
Minneapolis : University Of Minnesota
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Minneapolis :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Missouri
Kansas City : Kansas City Gastroenterology and Hepatology
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Kansas City : Kansas City Gastroenterology and Hepatology
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
St. Louis : Bruce Bacon M.D.
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
New Jersey
Hillsborough : ID Care, Inc. Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Newark : Saint Michael's Medical Center
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
New York
Manhasset : Biomedical Research Alliance of New York
Chronic Hepatitis B
View More »
Flushing : Office Of Sing Chan Md
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Flushing : Medical Procare, Pllc
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Flushing : 132-21 41 Ave. Suite 1A Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Great Neck : North Shore University Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : Mount Sinai Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
New York : Mount Sinai School Of Medicine
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
New York : Mount Sinai School of Medicine
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
New York :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
New York : New York Univ. Medical Center Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : Beth Israel Medical Center Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New York : Weill Cornell Medical College of Cornell University, 1305 York Ave. 4th floor Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Valhalla : New York Medical College
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
North Carolina
Charlotte : Levine Children'S Hospital At Carolinas Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Durham : Duke University Medical Center
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Wilmington : Registry Coordinating Center
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Winston-Salem : Wake Forest University Health Sciences Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Ohio
Cleveland : Case Western Reserve,11100 Euclid Avenue Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Oregon
Clackamas : Kaiser Permanente Sunnybrook Medical Office
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Portland : Kaiser Permanente Northwest
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Portland : Oregon Health Science University
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Pennsylvania
Philadelphia : Children'S Hospital Of Philadelphia
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Philadelphia : Children'S Hospital Of Philadelphia
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Philadelphia : 121 N. 9th Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Rhode Island
Providence : Rhode Island Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
South Carolina
Charleston : Medical Univ of South Carolina Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Tennessee
Texas
Arlington : The North Texas Research Institute Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Dallas : University Of Texas Southwestern Medical Center
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Houston : Texas Children'S Hospital
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Houston : Advanced Liver Therapies at St. Luke's Episcopal Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Houston : Kelsey Research Foundation Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Houston : Liver Associates of Texas, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Utah
Salt Lake City : University of Utah, 30 North 1900 East ,4R118 SOM Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Virginia
Fairfax : Inova Fairfax Hospital For Children
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Richmond : Liver Institute of Virginia, Bon Secours Health System Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Richmond : McGuire Research Institute Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Argentina
Bunos Aires : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Australia
Adelaide : Flinders Medical Center, 1 Flinders Drive,Bedford Park Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Adelaide SA : Royal Adelaide Hospital,Dept. of Gastroenterology and Hepatology, North Terrace Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Camperdown : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Camperdown : Royal Prince Alfred Hospital,AW Morrow Gastroenterology and Liver Center, Level 9 E- Block Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Clayton : Monash Medical Centre,Gastrointestinal and Liver Unit,246 Clayton Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Clayton Vic : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Concord : Concord Repatriation General Hospital,Department of Gastroenterology Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Fitzroy : Saint Vincents Hospital,Daly Wing 41 Victoria Parade Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Fremantle : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Fremantle : Fremantle Hospital,B2 Clinic, Alma Street, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Heidelberg Vic : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Herston : Royal Brisbane & Women's Hospital,C5 Clinical Sciences Building,Butterfield Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Kogarah : Saint George's Hospital,Pitney Building, Second Floor,Belgrave Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Liverpool : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Liverpool : Liverpool Hospital,Gastroenterology Department,Cr Elizabeth and Goulburn Streets Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Melbourne : The Alfred Hospital
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Melbourne : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Melbourne : The Alfred Hospital
HIV-HBV Co-Infection and Liver Disease
Melbourne : Alfred Hospital,Commercial Road/ Level 4 Main Ward Block Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Nedlands : Sir Charles Gairdner Hospital,Dept. of Gastroenterology Hepatology,6th Floor G Block Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Parkville : Royal Melbourne Hospital,Victorian Inf. Diseases Services,Grattan Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Perth : Royal Perth Hospital,Wellington Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Westmead : Storr Liver Unit- Westmead Hospital,Hawkesbury Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Westmead Nsw : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Austria
Graz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Innsbruck :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Linz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wien :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Belgium
Brussels : GSK Investigational Site
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
Brussels : Novartis Investigative Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Bruxelles : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bruxelles : GSK Investigational Site
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
Bosnia and Herzegovina
Banja Luka :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Mostar :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Sarajevo :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Tuzla :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Zenica :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Brazil
Porto Alegre : Local Institution
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Sco Paulo : Local Institution
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Bulgaria
Sofia :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Sofia : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Varna :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Varna : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Burkina Faso
Ouagadougou 01 : GSK Investigational Site
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
Canada
Calgary : Heritage Med Research Clinic, Univ of Calgary Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Edmonton : GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants.
Edmonton : GIRI GI Research Institute Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Montreal :
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
Toronto : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
View More »
Toronto : Toronto General Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toronto : Toronto Liver Centre Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Truro : GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants.
Vancouver : Gastrointestional Research Institute Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Vancouver : Gordon & Leslie Diamond Health Care Centre Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Vancouver : Liver and Intestinal Research Centre Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Zeidler Ledcore Centre : University of Alberta,Zeidler Ledcore Centre Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
China
Beijing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Beijing : Beijing Ditan Hospita
EFFORT Extension Study
Beijing : Beijing Friendship Hospital Attached To The Capital Medical University
EFFORT Extension Study
Beijing : Department of Infectious Disease, First Hospital of Peking University
EFFORT Extension Study
Beijing : 302 Military Hospital Of China
EFFORT Extension Study
View More »
Beijing : BeiJing YouAn Hospital ,Capital Medical University
EFFORT Extension Study
Beijing : People's Hospital Under Beijnig University
EFFORT Extension Study
Bejing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chang Chun : Hepatobiliary Disease Hospital of Jilin Province
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Changchun : First Hospital .Jilin Unniversity
EFFORT Extension Study
Changsha : Xiangya Hospital Central-South Univrsity
EFFORT Extension Study
Chengdu :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chengdu : West China Hospital.SiChuan University
EFFORT Extension Study
Chongqing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chongqing : The Second Affiliated of ChongQing University of Medical Science
EFFORT Extension Study
Guangzhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Guangzhou : No. 8 People's Hospital In GuangZhou
EFFORT Extension Study
Guangzhou : The Third Hospital of Sun Yat-Sen University
EFFORT Extension Study
Guangzhou : Department of Infectious Disease, Nanfang Hospital
EFFORT Extension Study
Hang Zhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hangzhou : The First Affiliated Hospital of College of Medicine, Zhejiang University
EFFORT Extension Study
Hangzhou : The Sixth People's Hospital of Hangzhou
EFFORT Extension Study
Hangzhou : Yangyida
Therapeutic Hepatitis B Vaccine (Synthesized Peptide εPA-44) Joint Entecavir in Treating Chronic Hepatitis B Patients
Harbin :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hong Kong : Department of Medicine, Queen Mary Hospital
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Jinan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Jinan : JiNan Infectious Diseases Hospital
EFFORT Extension Study
Nan Jing :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nan Jing : The Second Affiliated Hospital of the Southeast University
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Nanjing : No.81 Hospital of PLA
EFFORT Extension Study
Nanjing : Center for Disease Control and Prevention Jiangsu Province
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Shanghai :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shanghai : No.85 Hospital of PLA
EFFORT Extension Study
Shanghai : Changhai Hospital affiliated to Second Military Medical University
EFFORT Extension Study
Shanghai : Huashan Hospital，Fudan University
EFFORT Extension Study
Shanghai : Shanghai Ruijin Hospital
EFFORT Extension Study
Shen Yang :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shen Zhen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shengyang : ShengJing Hospital of China Medical University
EFFORT Extension Study
Shi Jiazhuang :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Shijiazhuang : The Fifth Hospital of Shijiazhuang
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Urumchi :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wen Zhou :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wuhan : Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
EFFORT Extension Study
Xian : Tangdu Hospital
EFFORT Extension Study
Xi'an :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Czech Republic
Brno : Fakultni nemocnice Brno
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Finland
Espoo : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Helsinki : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Jarvenpaa : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Kokkola : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Lahti : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
View More »
Oulu : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Pori : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Seinajoki : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Tampere : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Turku : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
Vantaa : GSK Investigational Site
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
France
Aix En Provence :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Amiens :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Angers :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Argenteuil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Avignon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
View More »
Besancon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bobigny :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bondy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bordeaux :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bourgoin Jallieu :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Caen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chambray-lès-tours :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clamart :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clermont-ferrand :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clichy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Clichy : Service Hepatologie- Centre Pierre Abrami Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Clichy Cedex : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Corbeil-essonnes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Creil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Creteil :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Creteil : Hopital Henri Mendor-Service d'HepatoGastroEnterologie
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Dijon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Grasse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lagny Sur Marne :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Le Kremlin-bicetre :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Le Mans :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lille :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Limoges :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lyon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Lyon : Hôpital de la Croix Rousse, Service Hepatogastro enterologie-endoscopie Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Lyon cedex 4 : Hopital de la Croix Rousse
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Marseille : Hôpital Saint Joseph, Service d'hépatogastroentérologie
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Marseille :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Metz :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montauban :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montivilliers :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Montpellier :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Mulhouse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nantes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Nice Cedex 03 : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Nimes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Niort :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Orleans :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Paris : Hopital Tenon, Service des Maladies Infectieuses
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Paris :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Paris : Hopital Tenon
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Paris : Hopital Tenon- 4 Rue de la Chine Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Paris : Hopital Cochin CIC de vaccinologie
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Paris Cedex 12 : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Perpignan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Pessac :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Reims :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rennes :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rennes Cedex 9 : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Rennes, 35 : CHU de Rennes,2 rue Henri Le Guilloux Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Rouen :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rouen : Hopital Charles Nicolle Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Saint Laurent Du Var :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
St Maurice :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Strasbourg :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Strasbourg : Centre Hospitalier Regional et Universitaire de Strasbourg, Hopital Civil Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Toulon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Toulouse :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Toulouse : Centre Hospitalier Universitaire Purpan Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Vandoeuvre-les-nancy :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Villejuif Cedex : Hopital Paul Brousse Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Germany
Berlin : EPIMED - Gesellschaft fuer epidemiologische und klinische Forschung in der Medizin mbH
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Berlin :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Berlin : Leberzentrum am Checkpoint
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Charite CVK
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Berlin : Charite Berlin, Campus Virchow-Klinikum- Augustenburger Platz 1 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Bonn : Universitaetsklinikum Bonn, Immunologische Ambulanz HIV
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Bonn : Universitaetsklinikum Bonn
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Duesseldorf : Zentrum für HIV und Hepatitis
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Essen : Universitätsklinikum Essen - klinikum für Gastroenterolgie und Hepatologie, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Essen : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Frankfurt : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Frankfurt : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Frankfurt : J.W. Goethe Universitaetsklinikum
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Frankfurt : Johann-Wolfgang-Goethe Universitat, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Frankfurt Am Main :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Freiburg : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Halle : Martin-Luther University Halle-Wittenberg
Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis
Hamburg : Universitaetsklinikum Hamburg-Eppendorf
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Hamburg : ifi - Studien und Projekte GmbH
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Hamburg :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hamburg : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Hamburg : Universitaetsklinikum Hamburg Eppendorf
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Hamburg : Asklepios Westklinikum Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Hamburg : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Hamm :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hannover :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hannover : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Hannover : Medizinische Hochschule Hannover
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Hannover : Medizinische Hochschule Hannover,Hastroenterologie und Hepatologie Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Heidelberg : Universitaetsklinik Heidelberg
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Herne : Gastroenterologische Gemeinschaftspraxis
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Herne : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Kiel : Gastroenterologische Gemeinschaftspraxis
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Koeln : Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Köln : Universitatsklinik Koln Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Leipzig : Universitaetsklinikum Leipzig
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Leipzig : Universitatsklinikum Leipzig Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Leipzig : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Magdeburg :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Mainz : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Mainz : Universitaetsklinikum Mainz
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Mainz : Johannes Gutenberg-Universitat Mainz, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Muenchen : Ludwig-Maximilians-Universitaet, Medizinische Poliklinik - Klinikum Innenstadt
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Muenchen : Klinikum der LMU Grosshadern
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
München :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Offenburg :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Starnberg : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Starnberg : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Stuttgart :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Tuebingen : Universitaetsklinik Tuebingen
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
ULM :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Ulm : Universitaetsklinikum Ulm
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Wuppertal : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Wuppertal : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Greece
Athens : Athens Univ Med School,Int Med 2nd,Vas Sofias Street 114 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Larissa :
A Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)
Patra : University Hospital of Patras,Department of Internal Medicine,Rio, Patra Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Thesaloniki : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Thessaloniki : Hippokration Hospital of Thessalonica,49 Konstantinoupoleous Str. Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Hong Kong
Hong Kong : University of Hong Kong ,Queen Mary Hospital,102 Pokfulan Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Kowloon : Princess Margaret Hospital,2-10 Princess Margaret Hosp Rd Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Pokfulam : Queen Mary Hospital
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
Shatin : Prince of Wales Hospital, 9/F, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Tai Po : Alice Ho Miu Ling Nethersole Hospital, 11 Chuen On Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Tuen Mun :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hungary
India
Chandigarh : School of Public Health, Post Graduate Institute of Medical Education and Research
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Coimbatore : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Guwahati : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Guwahati :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hyderabad : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
View More »
Pune :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Trivandrum :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Vijaywada : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Indonesia
Jakarta :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Surabaya :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Tangerang :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Ireland
Dublin :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Israel
Beer-Sheva : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Haifa : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Petach Tikva : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Zefat : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Italy
Bologna : Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola Malpighi
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Firenze : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Milano : Fondazione Centro San Raffaele del Monte Tabor Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Milano : Fondazione IRCCS Ca Granda - Ospedale Maggiore Policlinico,via Francesco Sforza 28/35 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Modena : A.O.U. Policlinico Università di Modena e Reggio Emilia
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
View More »
Napoli : Seconda Universita degli Studi di Napoli,via Cotugno 1 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Padova : Az. Ospedaliera Universitaria di Padova
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Pisa : Azienda Ospedaliero Universitaria Pisana
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Roma : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Roma : Fondazione PTV - Policlinico Tor Vergata,via Montpellier 1 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Rome : Policlinico Umberto I, Dipartimento di Malattie Infettive e Tropicali,v.le del Policlinico 155 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Torino : Az. Ospedaliera S.Giovanni Battista di Torino
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Japan
Aichi : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Aichi : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Chiba : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Chiba : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Fukui : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
View More »
Fukuoka : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Fukuoka : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Gifu : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Hiroshima : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Hiroshima : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Hokkaido : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Hyogo : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Kagawa : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Kagoshima : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Kagoshima : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Kanagawa : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Kanagawa : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Kumamoto : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Miyagi : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Miyagi : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Miyazaki : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Nagasaki : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Nara : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Okayama : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Osaka : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Saga : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Tokyo : GSK Investigational Site
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Tokyo : GSK Investigational Site Updated
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Jordan
Amman :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Korea, Republic of
Ansan-si : Korea University Ansan Hospital,516, Gojan 1-dong,516, Gojan 1-dong Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Bucheon : Soon Chun Hyang University Bucheon Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Busan : Inje University Haeundae Paik Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan : Dong-A University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
View More »
Busan : Kosin University Gospel Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Busan : Pusan National University Hospital,305 Gudeok-Ro Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Cheonan : Dankook University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Cheonan : SoonChunHyang University Hospital Cheonan,23-20, Byeongmyeong-dong, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Chooncheon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Chuncheon : Chuncheon Sacred Heart Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Daegu : Kyungpook National University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Yeungnam University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Daegu : Kyungpook National University Hospital,130 Dongduk-ro Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Daegu : Youngnam University Medical Center
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
Daejeon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Goyang : Inje University Ilsan Paik Hospital,2240, Daewha-dong,Ilsan seo-Gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Guri : Hanyang University Guri Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Incheon :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Jeju : Jeju National University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Jeonju :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Kwangjin-gu, Seoul : Digestive Disease Cntr, Konkuk Univ Hosp,4-12 Hwayang-dong Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seocho-gu, Seoul : Seoul Saint Mary''s Hospital,505 Banpo-dong Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seongnam : SKChemicals
A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients
Seoul : Updated
A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B
Seoul : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Seoul : Local Institution
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Seoul : Samsung Medical Center
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Seoul :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Seoul : Hanyang University Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Inje University Sanggye Paik Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangbuk Samsung Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangdong Sacred Heart Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangnam Severance Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Konkuk University Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kyunghee university Medical Center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Seoul : Kangnam St. Mary's Hospital
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
Seoul : Seoul National University Hospital,101 Daehak-ro,Jongno-Gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seoul : Severance Hospital,Yonsei University Health System,250 Seongsanno Seodaemun-gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seoul : Korea University Guro Hospital,80, Guro 2-dong,Guro-Gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seoul : Asan Medical Center,388-1 Pungnap-2-Dong Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seoul : Gangnam Severance Hospital,146-92 Dogok-Dong,Kangnam-gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Seoungnamsi :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Sungnam : Bundang CHA medical center
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Sungnam : CHA Bundang Medical Center, CHA University,351, Yatap-dong,Bundang-gu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Uijeongbu : Uijeongbu St.Mary's Hospital
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
Ulsan :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Wonju : Wonju Christian Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Wonju : Yonsei Unversity Wonju College of Medicine Wonju Christian Hospital,162 ilsan-dong Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Yangsan : Busan National University Yangsan Hospital
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
Yangsan : Pusan National University Yangsan Hospital,Beomeo-ri, Mulgeum-eup Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Lebanon
Beirut :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Macedonia, The Former Yugoslav Republic of
Skopje :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Morocco
Casablanca :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
FES :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Rabat :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Netherlands
Amsterdam : Vrije Universiteit Medisch Centrum,De Boelelaan 1117 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Amsterdam : Academisch Medisch Centrum Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Rotterdam : Erasmus MC,Afdeling Gastroenterologie,S Gravendijkwal, 230 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New Zealand
Auckland :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Hamilton :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Whakatane :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Philippines
Manila : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Quezon City : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Poland
Bialystok : Wojewodzki Szpital Specjalistyczny im Dluskeigo, ul Zurawia 14 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Bydgoszcz : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bydgoszcz : Wojewodzki Szpital Obserwacyjno - Zakazny im. Tadeusza Browicza w Bydgoszczy
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Bydgoszcz : Collegium Medicum Uniwersytet im. Mikołaja Kopernika
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Bydgoszcz : Klinika Chorob Zakaznych AM,Szpital Obserwacyno-Zakazny im.T.Browicza,ul. Sw. Floriana 12 Str. Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Krakow : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Krakow : Szpital Uniwersytecki w Krakowie,Klinika Chorob Zakaznych I Hepatologii,ul.Sniadeckich 5 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Szczecin : Samodzielny Publiczny Wojewódzki Szpital Zespolony
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Warsaw : Wojewódzki Szpital Zakaźny
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Warszawa : SPZOZ Wojewodzki Szpital Zakazny
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Warszawa : SP ZOZ Wojewodzki Szpital Zakazny w Warszawie,ul. Wolska 37 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Wroclaw : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Wrocław : NZOZ Centrum Badan Klinicznych
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Portugal
Lisboa : Hospital de Egas Moniz,Rua da Junqueira, 126 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Lisboa : Hospital de Santa Maria Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Porto : Centro Hospitalar do Porto,Serviço de Gastrenterologia,Largo Prof. Abel Salazar Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Puerto Rico
Ponce : Ararat Research Center
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
San Juan : University of Puerto Rico - School of Medicine
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Romania
Bucharest : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Bucharest :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Bucharest : nstitutul National de Boli Infectioase "Prof. Dr. Matei Bals" Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Bucharest : Institutul National de Boli Infectioase Prof.Dr. Matei Bals Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Bucharest : Spitalul Clinic de Boli Infectioase "Dr. Victor Babes" Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Bucuresti : Colentina Clinical Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Iasi : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Sibiu : Spitalul Clinic Judetean Sibiu Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Timisoara : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Timisoara :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Russian Federation
Moscow : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Novokuznetsk : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
St. Petersburg : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Saudi Arabia
Alkhobar :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Riyadh :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Tabuk :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Singapore
Singapore : Tan Tock Seng Hospital,11 Jalan Tan Tock Seng Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Singapore : National University Hospital Singapore,Div of Gastroenterology and Hepatology,1E Kent Ridge Road, Dept of Med Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Singapore : Singapore General Hospital,Ntnl Univ Hosp, Dept of Gastroenterology,Outram Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Singapore : Changi General Hospital,Division of Gastroenterology,Depart of Medicine, 2 Simei Street 3 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Spain
Barcelona : Hospital Universitari Vall d'Hebron
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Barcelona : Hospital General Universitari Vall d' Hebron Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Barcelona : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
El Palmar : Novartis Investigative Site
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Madrid : Hospital Universitario La Princesa Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
View More »
Madrid : Hospital Carlos III, Digestive Department, Sinesio Delgado 10 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Sevilla : Hospital Virgen de la Victoria Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Sevilla : Hospital Universitario Virgen del Rocio Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Valencia : Consorcio Hospital General Universitario de Valencia
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Vigo, Pontevedra : Hospital Meixoeiro,Meixoeiro, S/N Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taiwan
Changhua : Updated
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Chia-Yi : Chiayi Christian Hosp,Div. of Hepato-Gastro,No.539 ,Jhongsiao Rd Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Chia-Yi : Chia-Yi Christine Hospital Updated
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Hualien : Hualien Tzu Chi Med Ctr,Div. of Hepato-Gastro,No. 707, Sec. 3, Chung Yang Rd. Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Kaohsiung : Updated
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
View More »
Kaohsiung : E-Da Hospital Updated
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Kaosiung : Kaohsiung Medical University Hospital,Hepatobiliary Division,100 Shih-Chuan 1st Rd. Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Keelung City : Updated
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Keelung Town/KEELUNG CITY : Chang Gung Medical Foundation-Keelung,Chang Gung Med FDN -Keelung,No.222, Mai-Chin Road Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
New Taipei City : Far-Eastern Memorial Hosp,Div.of Hepato-Gastro,No.21, Sec. 2, Nanya S. Rd., Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taichung : Updated
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Taichung : China Medical University Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taichung : Taichung Veterans Genl Hosp,No. 160, Sec. 3, Chung-Kang Rd Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taichung : Taichung Veterans General Hospital Updated
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Tainan : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Tainan : National Cheng Kung University Hospital,Clin Pharm Outpatient Bldg 1F Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taipei : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Taipei : Local Institution
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Taipei : Updated
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Taipei : National Taiwan University Hospital Department of Internal medicine
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Taipei : Department of Internal Medicine
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Taipei : Taipei Veterans General Hospital-Division of Gastroenterology, Division of Oncology
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B
Taipei : National Taiwan University Hospital, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taipei : Cathay General Hospital,280 Jen-Ai Road, Sec. 4 Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Taoyuan : Local Institution
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Tao-Yuan : Chang Gung Memorial Hospital - Linkou,Chang Gung Univ Coll of Medicine,Number 5, Fu-Hsing Street Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Thailand
Bangkok :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
United Kingdom
Birmingham : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Birmingham : Novartis Investigator Site
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Birmingham, WSTMID : Queen Elizabeth Hospital, Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Hampstead,London : Royal Free Hospital Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
London : Local Institution
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
View More »
London : Harrison Wing Research Office, Guys and St. Thomas' NHS Foundation Trust
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
London : St Stephen's AIDS Trust
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
London :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
London : Barts & The London NHS Trust,Centre For Gastroenterology Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
London : King's College Hospital,Institute of Liver Studies Updated
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Manchester :
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
United States
Washington : Children'S National Medical Center
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Washington : Georgetown University Hospital
Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
